Advanced Biomed Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 31 Mar 2026
Net Income $6MTTM through 31 Mar 2026
Free Cash Flow -$1.4MTTM through 31 Mar 2026
Margins
| Current |
|---|
Returns
63.1%ROE
55.1%ROA
Balance Sheet Health
Debt / Equity0.06x
Net Debt-$2Mnet cash position
Cash & Equivalents$2.6M
Dividend
No dividend
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.